Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Pyott
AddedMar 31, 2024
UpdatedJun 28, 2026
David Pyott

David Pyott

Board Member, Philips

CrunchbaseLinkedIn

David Pyott's Career

Philips
Philips

Amsterdam, North Holland, NL

Board Member· Board
Pliant Therapeutics
Pliant Therapeutics

South San Francisco, CA, US

Board Member· Board
BioMarin
BioMarin

San Rafael, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Pyott's Career

Philips
Philips
Public$3.2B74.5k1891Amsterdam, North Holland, NL
Board Member· Board

Leadership at Philips

Feike SijbesmaFeike SijbesmaBoard Member
Roy JakobsRoy JakobsBoard Member
Indra NooyiIndra NooyiBoard Member
Sanjay PoonenSanjay PoonenBoard Member
Susim DattaSusim DattaBoard Member
Paul StoffelsPaul StoffelsBoard Member

Similar to Philips

Bleep SleepBleep SleepChapel Hill, NC, USCPAP, Medical Devices, Sleep Aidsest. 2015Bleep SleepChapel Hill, NC, US · est. 2015

Bleep Sleep develops FDA-cleared, headgear-free CPAP interfaces for sleep apnea therapy.

Seed · $3.4M10
Philips HealthcarePhilips HealthcareAndover, MA, USHealthcare Equipmentest. 1891Philips HealthcareAndover, MA, US · est. 1891

Massachusetts-based Philips division, manufacturing and servicing healthcare equipment.

Public2.8k
Siemens HealthineersSiemens HealthineersErlangen, Bavaria, DEDiagnostics, Medical Imagingest. 2017Siemens HealthineersErlangen, Bavaria, DE · est. 2017

Siemens Healthineers AG, a German medical tech firm, offers global healthcare solutions in imaging, diagnostics, and digital ecosystems.

Public · $2.3B69.5k
Omron HealthcareOmron HealthcareLake Forest, IL, USHealthcare, Wellnessest. 1933Omron HealthcareLake Forest, IL, US · est. 1933

Omron Healthcare: Precision wellness products for fitness, blood pressure monitoring, pain relief, and respiratory care.

Public354
Pliant Therapeutics
Pliant Therapeutics
Public$694.9M1242015South San Francisco, CA, US
Board Member· Board

Leadership at Pliant Therapeutics

Charles HomcyCharles HomcyBoard Member
Perry KarsenPerry KarsenBoard Member
Katharine KnobilKatharine KnobilBoard Member
Suzanne BruhnSuzanne BruhnBoard Member
Bernard CoulieBernard CoulieBoard Member
Thomas McCourtThomas McCourtBoard Member
BioMarin
BioMarin
Public$585.8M3.1k1997San Rafael, CA, US
Board Member· Board

Leadership at BioMarin

Liz McKee AndersonLiz McKee AndersonBoard Member
Willard DereWillard DereBoard Member
Randy MeierRandy MeierBoard Member
Alexander HardyAlexander HardyCEO
Mark AllesMark AllesBoard Member
Christopher M. StarrChristopher M. StarrCo-Founder

Similar to BioMarin

BioCryst PharmaceuticalsBioCryst PharmaceuticalsDurham, NC, USPharmaceuticalsest. 1986BioCryst PharmaceuticalsDurham, NC, US · est. 1986

BioCryst Pharmaceuticals: A global biotech firm innovating oral treatments for rare diseases.

Public · $1.8B531
Marinus PharmaceuticalsMarinus PharmaceuticalsRadnor, PA, USMedical Drugsest. 2003Marinus PharmaceuticalsRadnor, PA, US · est. 2003

US-based Marinus Pharmaceuticals develops and commercializes medical drugs for serious neurological and psychiatric disorders.

Public · $406.9M151
Ionis PharmaceuticalsIonis PharmaceuticalsCarlsbad, CA, USPharmaceuticalsest. 1989Ionis PharmaceuticalsCarlsbad, CA, US · est. 1989

Ionis Pharmaceuticals: A US-based biotech firm specializing in RNA-targeted drug discovery for unmet needs.

Public · $1.3B796
PTC TherapeuticsPTC TherapeuticsSouth Plainfield, NJ, USPharmaceuticalsest. 1998PTC TherapeuticsSouth Plainfield, NJ, US · est. 1998

PTC Therapeutics, Inc.: A US-based pharmaceutical company specializing in oral, small-molecule drugs for genetic disorders, oncology, and infectious diseases.

Public · $1.6B1.4k

David Pyott's Co-Investors

Gerry ProehlGerry ProehlCo-invested · Zerigo Health SeedDavid F. HaleDavid F. HaleCo-invested · Zerigo Health SeedYann PhungYann PhungCo-invested · Zerigo Health Seed

David Pyott's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to David Pyott

Jerry LegertonJerry LegertonCo-Founder · InnovegaJack CooperJack CooperBoard Member · TraceLinkDon HarrisonDon HarrisonBoard Member · Charter Life SciencesSean IanchulevSean IanchulevBoard Member · Hyperion DeFiGrant AllenGrant AllenCo-Founder · ABB Technology VenturesHoward RossmanHoward RossmanBoard Member · Mesirow Financial